title: Back From the Brink: The Uses of Targeting the CXCL10:CXCR3 Axis in Type 1 Diabetes.
authors.affiliation: Diabetes, Obesity and Metabolism Institute and Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY dirk.homann@mssm.edu.
authors.forename: Dirk
authors.initials: D
authors.lastname: Homann
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D015551:Autoimmunity / Q000187:drug effects*; D017252:CD3 Complex / Q000737:chemistry*; D054357:Chemokine CXCL10 / Q000037:antagonists & inhibitors*; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy*; D004195:Disease Models, Animal; D005260:Female; D007515:Islets of Langerhans / Q000187:drug effects*
chemical_list: D000911:Antibodies, Monoclonal; D017252:CD3 Complex; D054357:Chemokine CXCL10